Cellular Therapy
Meeting News
Video Interviews
Drs. Shah, Jain Discuss CAR-T Cell Therapy Advances at SOHO 2024
In this video interview from the Twelfth Annual Meeting of the Society of Hematologic Oncology (SOHO), Bijal Shah, MD, of the Moffitt Cancer
Lymphoma
Indolent B-Cell Lymphomas
US FDA approves epcoritamab for relapsed or refractory follicular lymphoma
The US Food and Drug Administration (FDA) has approved epcoritamab-bysp (EPKINLY) for the treatment of adults with relapsed or refractory follicular lymphoma after
Multiple Myeloma
FDA approves daratumumab plus hyaluronidase – based quadruplet therapy
The US Food and Drug Administration (FDA) has approved daratumumab and hyaluronidase-fihj (Darzalex Faspro) in combination with bortezomib, lenalidomide, and dexamethasone (D-VRd) for
Leukemia
Acute Lymphoblastic Leukemia
Acute Myeloid Leukemia
Chronic Lymphocytic Leukemia
Chronic Myeloid Leukemia
Roundtable Discussions
Drs. Kantarjian, Litzow Discuss Blinatumomab Breakthrough in E1910 Trial
https://youtu.be/xP3dZWHtfKs In this video filmed at the Twelfth Annual Meeting of the Society of Hematologic Oncology (SOHO 2024), Hagop Kantarjian,MD, professor and chair
Leukemia
Acute Myeloid Leukemia
Roundtable Discussions
Video Interviews
Dr. Craddock Issues Rallying Cry to Leukemia Transplant Community
Hagop Kantarjian, MD, professor and chair in the Department of Leukemia at the University of Texas MD Anderson Cancer Center, sits down with
Leukemia
Acute Lymphoblastic Leukemia
Acute Myeloid Leukemia
Chronic Lymphocytic Leukemia
Chronic Myeloid Leukemia
Is Blinatumomab Plus Chemotherapy in MRD-Negative BCP-ALL Superior to Chemotherapy-alone?
The addition of the bispecific T-cell engager blinatumomab to consolidation chemotherapy in adults patients with BCR::ABL1-negative B-cell precursor acute lymphoblastic leukemia (BCP-ALL) who had
Society Updates
SOHO President Dr. Scheinberg Announces Joint Session With ABHH in Brazil in October
For the first time in history, the Society of Hematologic Oncology (SOHO) is holding a joint session with the Brazilian Association of Hematology,